These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 2548824)
1. [A new herpes virus]. Linnavuori K; Vaheri A Duodecim; 1989; 105(12):1161-4. PubMed ID: 2548824 [No Abstract] [Full Text] [Related]
2. Monoclonal B cell proliferation in lymphoproliferative disease associated with herpes virus type 6 infection. Berthold F; Krueger GR; Tesch H; Hiddemann W Anticancer Res; 1989; 9(6):1511-8. PubMed ID: 2560619 [TBL] [Abstract][Full Text] [Related]
3. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055 [TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Mathur A; Kamat DM; Filipovich AH; Steinbuch M; Shapiro RS Transplantation; 1994 Apr; 57(7):1042-5. PubMed ID: 8165700 [TBL] [Abstract][Full Text] [Related]
5. [Human B-lymphotropic virus (HBLV): human herpesvirus-6 (HHV-6)]. Us D; Hayran M Mikrobiyol Bul; 1989 Apr; 23(2):174-7. PubMed ID: 2560528 [TBL] [Abstract][Full Text] [Related]
6. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Dolcetti R Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317 [TBL] [Abstract][Full Text] [Related]
7. [Double-marker (T + B) lymphocytes in lymphoproliferative diseases]. Pecze K; Dalmi L; Rák K Orv Hetil; 1982 Jun; 123(26):1595-7. PubMed ID: 6981087 [No Abstract] [Full Text] [Related]
8. A new human herpesvirus. Weiss R; Mulder C Nature; 1986 Oct 30-Nov 5; 323(6091):762. PubMed ID: 3490624 [No Abstract] [Full Text] [Related]
9. Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals. Purtilo DT; Klein G Cancer Res; 1981 Nov; 41(11 Pt 1):4209. PubMed ID: 6272963 [No Abstract] [Full Text] [Related]
10. The changing faces of EBV research. Klein G; Klein E Prog Med Virol; 1984; 30():87-106. PubMed ID: 6087416 [No Abstract] [Full Text] [Related]
11. New oncologic associations for the Epstein-Barr virus. Gartner JG; Seemayer TA Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684 [No Abstract] [Full Text] [Related]
12. [Recent aspects of Epstein-Barr virus infections]. Hasler F Schweiz Med Wochenschr; 1984 Apr; 114(15):520-3. PubMed ID: 6328644 [TBL] [Abstract][Full Text] [Related]
13. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. Klein G; Purtilo D Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974 [No Abstract] [Full Text] [Related]
14. [Spectrum of lymphoproliferative diseases]. Franssila K Duodecim; 1989; 105(11):1016-39. PubMed ID: 2666087 [No Abstract] [Full Text] [Related]
15. Crystalline inclusions in B monoclonal lymphocytes. Girodon F; Poillot N; Martin I; Carli PM; Maynadié M Haematologica; 2004 Nov; 89(11):ECR40. PubMed ID: 15533845 [No Abstract] [Full Text] [Related]
16. Possible association between the observed cyclosporine-induced upregulation of in vitro immune functions and posttransplantation lymphoproliferative disorders. Degiannis D; Hornung N J Heart Lung Transplant; 1994; 13(6):1145-6. PubMed ID: 7865523 [No Abstract] [Full Text] [Related]